STOCK TITAN

PepGen (PEPG) awards director 34,000 options vesting by next meeting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PepGen Inc. reported that director Lisa Wyman received a grant of stock options covering 34,000 shares of common stock. The options have an exercise price of $1.79 per share and expire on June 17, 2036. They vest in full on the earlier of the first anniversary of the grant date or the next annual meeting, subject to continued service as a director.

Positive

  • None.

Negative

  • None.
Insider Wyman Lisa
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 34,000 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 34,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 34,000 options Grant to director Lisa Wyman
Exercise price $1.79 per share Stock option strike price
Expiration date June 17, 2036 Option term end
Underlying shares 34,000 shares Common stock underlying options
Total options after grant 34,000 options Derivative holdings following transaction
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "1.7900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-17T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Annual Meeting financial
"the date of the next Annual Meeting; provided, however, that all vesting"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
vest financial
"This option shall vest in full upon the earlier of (i) the first anniversary"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wyman Lisa

(Last)(First)(Middle)
C/O PEPGEN INC.
321 HARRISON AVE., 8TH FLOOR

(Street)
BOSTON MASSACHUSETTS 02118

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PepGen Inc. [ PEPG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$1.7906/18/2026A34,000 (1)06/17/2036Common Stock34,000$034,000D
Explanation of Responses:
1. This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting.
/s/ Noel Donnelly, as attorney-in-fact06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did PepGen (PEPG) disclose about Lisa Wyman in this Form 4?

PepGen disclosed that director Lisa Wyman received a grant of stock options for 34,000 shares. These options are a form of equity compensation, allowing her to buy PepGen common stock at a fixed exercise price if the options vest and are exercised.

How many PepGen (PEPG) stock options were granted to Lisa Wyman?

Lisa Wyman was granted stock options covering 34,000 shares of PepGen common stock. This entire amount is reflected as her derivative holdings following the transaction, indicating the grant created a new options position rather than modifying an existing one.

What is the exercise price of Lisa Wyman’s PepGen (PEPG) stock options?

The stock options granted to Lisa Wyman have an exercise price of $1.79 per share. This means she can buy PepGen common stock at $1.79 per share if the options vest and she chooses to exercise them before expiration.

When do Lisa Wyman’s PepGen (PEPG) stock options vest?

The options will vest in full on the earlier of the first anniversary of the grant date or the date of the next annual meeting. Vesting continues only while she serves as a director, unless the board decides to allow vesting to continue despite her departure.

What is the expiration date of Lisa Wyman’s PepGen (PEPG) options?

Lisa Wyman’s stock options expire on June 17, 2036. She must exercise any vested options before this expiration date; after that, unexercised options will lapse and can no longer be used to purchase PepGen common shares.

Is this PepGen (PEPG) Form 4 a stock purchase or compensation grant?

This Form 4 reflects a compensation-related grant of stock options, not an open-market stock purchase. The options were awarded with a grant code indicating a grant or award acquisition and carry an exercise price and vesting conditions typical of director compensation.